TIANYIN PHARMACEUTICAL
TPI
TPI was delisted on the 29th of April, 2016.
9 hedge funds and large institutions have $352K invested in TIANYIN PHARMACEUTICAL in 2015 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 0 closing their positions.
50% more funds holding
Funds holding: 6 → 9 (+3)
41% less capital invested
Capital invested by funds: $600K → $352K (-$248K)
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$18.8K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$8.27K |
| 3 |
Creative Planning
Overland Park,
Kansas
|
+$4.35K |
| 4 |
Renaissance Technologies
New York
|
+$2.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.01K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $134K | +$2.5K | +11,500 | +1% |
|
|
PAM
2
Pope Asset Management
Memphis,
Tennessee
| $124K | – | – | – |
|
3
California Public Employees Retirement System
Sacramento,
California
| $56K | – | – | – |
|
|
4
Citadel Advisors
Miami,
Florida
| $18K | +$18.8K | +86,435 | +400% |
|
|
CHP
5
Cable Hill Partners
Portland,
Oregon
| $10K | – | – | – |
|
|
VKH
6
Virtu KCG Holdings
New York
| $6K | +$8.27K | +37,981 | New |
|
|
7
Creative Planning
Overland Park,
Kansas
| $3K | +$4.35K | +20,000 | New |
|
|
8
UBS Group
Zurich,
Switzerland
| $1K | +$1.01K | +4,629 | +123% |
|
|
LTFS
9
Ladenburg Thalmann Financial Services
Miami,
Florida
| – | +$109 | +500 | New |
|
TPI Hedge Fund Activity: Q4 2015 in Review
9 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in TIANYIN PHARMACEUTICAL (TPI) for Q4 2015, worth a combined $352K — down 41% from $600K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new TPI positions and 0 closed out — a net gain of 3 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $18.8K.
- 9 institutional investors held TIANYIN PHARMACEUTICAL (TPI) as of Q4 2015, up from 6 in Q3 2015.
- Funds reported $352K of TIANYIN PHARMACEUTICAL stock for Q4 2015, down 41% quarter-over-quarter.
- 3 funds opened new TIANYIN PHARMACEUTICAL positions in Q4 2015 and 0 closed out, a net change of +3 holders.
- The largest TIANYIN PHARMACEUTICAL buyer in Q4 2015 was Citadel Advisors, an estimated $18.8K added.
Based on aggregated 13F filings for Q4 2015.